AMR Bio urges US policymakers to make infection prevention a core AMR strategy Manufacturing Chemist 10:47
EMV Capital and advances with AMR Bio’s XF-73 drug - ICYMI Proactive Investors (UK) 06:46 Sat, 30 May
AMR Bio launches with phase 3-ready antimicrobial gel targeting surgical infections PMLiVE 12:56 Thu, 21 May
AMR Bio launches as clinical-phase biotech to advance Phase III-ready topical antimicrobial XF-73 Manufacturing Chemist 12:38 Thu, 21 May
EMV Capital's AMR Bio advances infection-prevention drug towards phase III trial Proactive Investors (UK) 07:39 Thu, 21 May
